뒤로
BioArctic AB (BRCTF) 수입
BRCTF 주가 차트
BRCTF 수입
BioArctic AB
$33.02
0%
$0
종가: Mar 24, 16:00:00 GMT-4
$33.02
0%
$0
애프터마켓: Mar 24, 17:21:00 GMT-4
주요 통계
이전 종가
$33.02
시가
$38
일일 범위
$33.02 - $38
52주 범위
$15.49 - $36.83
거래량
200
평균 거래량
87
배당수익률
--
EPS(TTM)
1.22
시가총액
$2.4B
BIOARCTIC AB란 무엇인가요?
BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. The company is headquartered in Stockholm, Stockholm and currently employs 131 full-time employees. The company went IPO on 2017-10-12. The firm focuses on the research and development of treatments, which aim at diseases that affect the central nervous system (CNS). Its therapeutic areas encompass neurodegenerative disorders, Alzheimer's disease, Parkinson's disease, complete spinal cord injury, as well as other CNS disorders. The firm owns a technology platform, which develops a range of therapeutic monoclonal antibodies. The firm's pipeline includes product candidates in various clinical phases, such as BAN2401, AE1501, BAN0805, imaging and biochemical biomarkers, BBB-technology and SC0806. The firm also operates through SpineMedical AB.